Omeros | OMER - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Adma Biologics USD 73.54M 4M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cytokinetics USD 199.18M 3.27M 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
Immunic USD 38.36M 7.74M 2026-03
Insmed USD 361.01M 107.87M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
MacroGenics USD 95.94M 52.82M 2026-03
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 108.79M 11.8M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Rockwell Medical USD 10.95M 259K 2025-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Xoma USD 28.3M 6.81M 2025-09